EDAP Quote, Financials, Valuation and Earnings

Biodexa Pharmaceuticals PLC has a net margin of -52.18% compared to Edap TMS SA's net margin of --. Edap TMS SA's return on equity of -49.1% beat Biodexa Pharmaceuticals PLC's return on equity of -160.77%.

Edap TMS SA has a consensus price target of $5.75, signalling upside risk potential of 291.16%. On the other hand Biodexa Pharmaceuticals PLC has an analysts' consensus of $17.94 which suggests that it could grow by 2041.28%. Given that Biodexa Pharmaceuticals PLC has higher upside potential than Edap TMS SA, analysts believe Biodexa Pharmaceuticals PLC is more attractive than Edap TMS SA.

Edap TMS SA has a beta of -0.003, which suggesting that the stock is 100.255% less volatile than S&P 500. In comparison Biodexa Pharmaceuticals PLC has a beta of 1.167, suggesting its more volatile than the S&P 500 by 16.654%.

Edap TMS SA has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Biodexa Pharmaceuticals PLC offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Edap TMS SA pays -- of its earnings as a dividend. Biodexa Pharmaceuticals PLC pays out -- of its earnings as a dividend.

Edap TMS SA quarterly revenues are $14.3M, which are larger than Biodexa Pharmaceuticals PLC quarterly revenues of --. Edap TMS SA's net income of -$7.4M is higher than Biodexa Pharmaceuticals PLC's net income of --. Notably, Edap TMS SA's price-to-earnings ratio is -- while Biodexa Pharmaceuticals PLC's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Edap TMS SA is 0.82x versus 0.87x for Biodexa Pharmaceuticals PLC. Usually stocks with elevated PS ratios are considered overvalued.

Cellectis SA has a net margin of -52.18% compared to Edap TMS SA's net margin of -170.14%. Edap TMS SA's return on equity of -49.1% beat Cellectis SA's return on equity of -49.15%.

Edap TMS SA has a consensus price target of $5.75, signalling upside risk potential of 291.16%. On the other hand Cellectis SA has an analysts' consensus of $5.75 which suggests that it could grow by 188.95%. Given that Edap TMS SA has higher upside potential than Cellectis SA, analysts believe Edap TMS SA is more attractive than Cellectis SA.

Edap TMS SA has a beta of -0.003, which suggesting that the stock is 100.255% less volatile than S&P 500. In comparison Cellectis SA has a beta of 2.910, suggesting its more volatile than the S&P 500 by 191%.

Edap TMS SA has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Cellectis SA offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Edap TMS SA pays -- of its earnings as a dividend. Cellectis SA pays out -- of its earnings as a dividend.

Edap TMS SA quarterly revenues are $14.3M, which are larger than Cellectis SA quarterly revenues of $10.7M. Edap TMS SA's net income of -$7.4M is higher than Cellectis SA's net income of -$18.1M. Notably, Edap TMS SA's price-to-earnings ratio is -- while Cellectis SA's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Edap TMS SA is 0.82x versus 4.08x for Cellectis SA. Usually stocks with elevated PS ratios are considered overvalued.

DBV Technologies SA has a net margin of -52.18% compared to Edap TMS SA's net margin of --. Edap TMS SA's return on equity of -49.1% beat DBV Technologies SA's return on equity of --.

Edap TMS SA has a consensus price target of $5.75, signalling upside risk potential of 291.16%. On the other hand DBV Technologies SA has an analysts' consensus of $16.06 which suggests that it could grow by 64.81%. Given that Edap TMS SA has higher upside potential than DBV Technologies SA, analysts believe Edap TMS SA is more attractive than DBV Technologies SA.

Edap TMS SA has a beta of -0.003, which suggesting that the stock is 100.255% less volatile than S&P 500. In comparison DBV Technologies SA has a beta of -0.587, suggesting its less volatile than the S&P 500 by 158.693%.

Edap TMS SA has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. DBV Technologies SA offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Edap TMS SA pays -- of its earnings as a dividend. DBV Technologies SA pays out -- of its earnings as a dividend.

Edap TMS SA quarterly revenues are $14.3M, which are larger than DBV Technologies SA quarterly revenues of --. Edap TMS SA's net income of -$7.4M is higher than DBV Technologies SA's net income of -$27.1M. Notably, Edap TMS SA's price-to-earnings ratio is -- while DBV Technologies SA's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Edap TMS SA is 0.82x versus -- for DBV Technologies SA. Usually stocks with elevated PS ratios are considered overvalued.

Genfit SA has a net margin of -52.18% compared to Edap TMS SA's net margin of --. Edap TMS SA's return on equity of -49.1% beat Genfit SA's return on equity of --.

Edap TMS SA has a consensus price target of $5.75, signalling upside risk potential of 291.16%. On the other hand Genfit SA has an analysts' consensus of $8.70 which suggests that it could grow by 126.92%. Given that Edap TMS SA has higher upside potential than Genfit SA, analysts believe Edap TMS SA is more attractive than Genfit SA.

Edap TMS SA has a beta of -0.003, which suggesting that the stock is 100.255% less volatile than S&P 500. In comparison Genfit SA has a beta of 1.082, suggesting its more volatile than the S&P 500 by 8.244%.

Edap TMS SA has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Genfit SA offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Edap TMS SA pays -- of its earnings as a dividend. Genfit SA pays out -- of its earnings as a dividend.

Edap TMS SA quarterly revenues are $14.3M, which are larger than Genfit SA quarterly revenues of --. Edap TMS SA's net income of -$7.4M is higher than Genfit SA's net income of --. Notably, Edap TMS SA's price-to-earnings ratio is -- while Genfit SA's PE ratio is 32.57x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Edap TMS SA is 0.82x versus 2.66x for Genfit SA. Usually stocks with elevated PS ratios are considered overvalued.